Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment
Silvia Betti, Elena Rossi, Valerio De Stefano, et al.
Thrombosis and Haemostasis (2015) Vol. 115, Iss. 02, pp. 240-249
Closed Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

ACG Clinical Guideline: Disorders of the Hepatic and Mesenteric Circulation
Douglas A. Simonetto, Ashwani K. Singal, Guadalupe García‐Tsao, et al.
The American Journal of Gastroenterology (2020) Vol. 115, Iss. 1, pp. 18-40
Closed Access | Times Cited: 169
Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis
Virginia Hernández‐Gea, Andrea De Gottardi, Frank W.G. Leebeek, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 1, pp. 175-199
Open Access | Times Cited: 106
Thromboembolic events in polycythemia vera
Martin Grießhammer, Jean‐Jacques Kiladjian, Carlos Besses
Annals of Hematology (2019) Vol. 98, Iss. 5, pp. 1071-1082
Open Access | Times Cited: 105
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
Valerio De Stefano, Alessandro M. Vannucchi, Marco Ruggeri, et al.
Blood Cancer Journal (2016) Vol. 6, Iss. 11, pp. e493-e493
Open Access | Times Cited: 95
Cancer associated thrombosis: risk factors and outcomes
Sabine Eichinger
Thrombosis Research (2016) Vol. 140, pp. S12-S17
Closed Access | Times Cited: 91
Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features
Anna Guadall, Élodie Lesteven, Gil Letort, et al.
Thrombosis and Haemostasis (2018) Vol. 118, Iss. 09, pp. 1586-1599
Closed Access | Times Cited: 73
Review article: the aetiology of primary Budd-Chiari syndrome - differences between the West and China
X. Qi, Guohong Han, Xiaozhong Guo, et al.
Alimentary Pharmacology & Therapeutics (2016) Vol. 44, Iss. 11-12, pp. 1152-1167
Open Access | Times Cited: 69
Clinical insights into the origins of thrombosis in myeloproliferative neoplasms
Alison R. Moliterno, Yelena Ginzburg, Ronald Hoffman
Blood (2020) Vol. 137, Iss. 9, pp. 1145-1153
Open Access | Times Cited: 69
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry
Nicoletta Riva, Walter Ageno, Sam Schulman, et al.
The Lancet Haematology (2016) Vol. 3, Iss. 6, pp. e267-e275
Closed Access | Times Cited: 62
Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia
Radhika Gangaraju, Jihyun Song, Soo Jin Kim, et al.
Blood Advances (2020) Vol. 4, Iss. 6, pp. 1115-1130
Open Access | Times Cited: 62
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases
Emanuela Sant’Antonio, Paola Guglielmelli, Lisa Pieri, et al.
American Journal of Hematology (2019) Vol. 95, Iss. 2, pp. 156-166
Open Access | Times Cited: 60
Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis
Christoph Klinger, Bettina Riecken, Arthur Schmidt, et al.
Digestive and Liver Disease (2017) Vol. 49, Iss. 12, pp. 1345-1352
Closed Access | Times Cited: 62
Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018
Guido Finazzi, Valerio De Stefano, Tiziano Barbui
Blood Cancer Journal (2018) Vol. 8, Iss. 7
Open Access | Times Cited: 56
Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms
Deepa Rj Arachchillage, Michael Laffan
Seminars in Thrombosis and Hemostasis (2019) Vol. 45, Iss. 06, pp. 604-611
Open Access | Times Cited: 54
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms
Lisa Pieri, Chiara Paoli, Umberto Arena, et al.
American Journal of Hematology (2016) Vol. 92, Iss. 2, pp. 187-195
Open Access | Times Cited: 51
Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease
Joan How, Amy Zhou, Stephen T. Oh
Therapeutic Advances in Hematology (2016) Vol. 8, Iss. 3, pp. 107-118
Open Access | Times Cited: 51
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights
Erika Morsia, Elena Torre, Francesco Martini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1524-1524
Open Access | Times Cited: 5
Essential thrombocythemia: challenges in clinical practice and future prospects
Anna L. Godfrey, Anna Green, Claire Harrison
Blood (2022) Vol. 141, Iss. 16, pp. 1943-1953
Closed Access | Times Cited: 20
Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology
Yuh Cai Chia, Siti Asmaa Mat Jusoh, Marini Ramli, et al.
Diagnostics (2023) Vol. 13, Iss. 1, pp. 163-163
Open Access | Times Cited: 13
Splanchnic Vein Thrombosis: The State-of-the-Art on Anticoagulant Treatment
Scott Custo, Emma Tabone, Alexia Aquilina, et al.
Hämostaseologie (2024) Vol. 44, Iss. 04, pp. 242-254
Open Access | Times Cited: 4
Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper
Tiziano Barbui, Valerio De Stefano, Anna Falanga, et al.
Blood Cancer Journal (2019) Vol. 9, Iss. 8
Open Access | Times Cited: 31
JAK2 allele burden is correlated with a risk of venous but not arterial thrombosis
Simon Soudet, Gaëlle Le Roy, Estelle Cadet, et al.
Thrombosis Research (2022) Vol. 211, pp. 1-5
Open Access | Times Cited: 17
Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature
Mihnea‐Alexandru Găman, Matei-Alexandru Cozma, Muhammad Romail Manan, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 3, pp. 99-116
Open Access | Times Cited: 10
Etiology and Risk Factors for Splanchnic Vein Thrombosis in Non-Cirrhotic, Non-Neoplastic Patients: A Narrative Review
Mihaela Hostiuc, Ionuţ Negoi
Medicina (2025) Vol. 61, Iss. 5, pp. 933-933
Open Access
Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era
Lorenzo Falchi, H. Kantarjian, Srđan Verstovšek
Leukemia (2017) Vol. 31, Iss. 9, pp. 1845-1854
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top